Label reference · Infectious diseases
Mavyret (Glecaprevir And Pibrentasvir) Tablet, Film Coated Mavyret (Glecaprevir And Pibrentasvir) Pellet — label reference
DailyMed · Retrieved 2026-10-13
Mavyret is listed in DailyMed as tablet, film coated; pellet. Active ingredients: pibrentasvir; glecaprevir. This reference records product facts and version 201; the original prescribing information and PDF are linked.
Reference details
- Brand / product name
- Mavyret
- Generic product name
- Glecaprevir and Pibrentasvir
- Active ingredient
- PIBRENTASVIR; GLECAPREVIR
- Dosage form
- TABLET, FILM COATED; PELLET
- Route
- ORAL
- SPL author / labeler
- AbbVie Inc.
- SPL version
- 201
- Published on DailyMed
- 2026-08-07
- SPL effective date
- 2025-06-25
- SPL set ID
- 7bf99777-0401-9095-8645-16c6e907fcc0
Product identity
Product name: Mavyret
Generic name: Glecaprevir and Pibrentasvir
Active ingredients: PIBRENTASVIR; GLECAPREVIR
Dosage form: TABLET, FILM COATED; PELLET
Route: ORAL
Label version
DailyMed published this record on 2026-08-07. SPL version: 201. Set ID: 7bf99777-0401-9095-8645-16c6e907fcc0. The SPL effective date is 2025-06-25.
Original prescribing information
Open the original DailyMed label or PDF below for indications, contraindications, dosing instructions, interactions and warnings. This page contains factual product metadata, not the full prescribing information.
Sources and reuse
- Original DailyMed label
- Original label PDF
- Official SPL XML
- Factual label metadata; original label linked
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2026-08-07. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.